Your session is about to expire
← Back to Search
Vitamin D Supplement
1 for Kidney Transplant
N/A
Waitlist Available
Led By Jennifer L Larsen, MD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial found that people who were deficient in Vitamin D were more likely to have a worsening of their vascular risks after a kidney transplant.
Eligible Conditions
- Kidney Transplant
- Vitamin D Deficiency
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Standard vitamin treatment
Group II: 2Active Control1 Intervention
50,000 I.U. of vitamin D3
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
vitamin D3
2010
Completed Phase 4
~4400
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
554 Previous Clinical Trials
1,145,271 Total Patients Enrolled
Jennifer L Larsen, MDPrincipal InvestigatorUniversity of Nebraska
1 Previous Clinical Trials
338 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger